Skip to Content

Pfizer CRZ 250 (Xalkori 250 mg)

Generic Name: crizotinib

Pill with imprint Pfizer CRZ 250 is Pink, Capsule-shape and has been identified as Xalkori 250 mg. It is supplied by Pfizer Inc..

Xalkori is used in the treatment of non-small cell lung cancer and belongs to the drug class multikinase inhibitors. There is positive evidence of human fetal risk during pregnancy. Xalkori 250 mg is not a controlled substance under the Controlled Substance Act (CSA).

Images for Pfizer CRZ 250

Xalkori

Generic Name:
crizotinib
Imprint:
Pfizer CRZ 250
Strength:
250 mg
Color:
Pink
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Multikinase inhibitors
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Pfizer Inc.
National Drug Code (NDC):
00069-8140

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide